# Study of CM310 in Subjects With Allergic Rhinitis

> **NCT05908032** · PHASE3 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 108 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **BIOLOGICAL:** CM310
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05908032
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-10
- **Primary completion:** 2023-12-04
- **Final completion:** 2023-12-04
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05908032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05908032, "Study of CM310 in Subjects With Allergic Rhinitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05908032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*